Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple Sclerosis: Diagnostic and Treatment Frontiers
Letter to the Editor: Trigeminal neuralgia in patients with multiple sclerosis.
Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor.
Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?
Papers: 4 Sep 2015 - 11 Sep 2015
MS Research Roundup: June 19, 2014
Papers: 12 Dec 2014 - 19 Dec 2014
MS Research Roundup: April 4, 2014
Papers: 29 May 2015 - 5 Jun 2015
MS Research Roundup: August 29, 2014
Papers: 13 Dec 2015 - 20 Dec 2015
Papers: 15 May 2015 - 22 May 2015
Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach.
Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.
Papers: 19 Sep 2015 - 26 Sep 2015
Gray matter imaging in multiple sclerosis: what have we learned?
MRI monitoring of spinal cord changes in patients with multiple sclerosis.
MRI in multiple sclerosis: what's inside the toolbox?
Disappearing MS T2 lesions may have persistent tissue injury by diffusion tensor and magnetisation transfer imaging
Papers: 3 Jul 2015 - 10 Jul 2015
The Characteristics of Multiple Sclerosis in Iran.
Is progressive multiple sclerosis a gray matter disease?
Papers: 24 Apr 2015 - 1 May 2015
Papers: 28 Mar 2016 - 4 Apr 2016
Papers: 10 Oct 2014 - 17 Oct 2014
Pages
« first
‹ previous
…
24
25
26
27
28
29
30
31
32
…
next ›
last »
